Risbon 75 mg filmom obložene tablete
| Name | Risbon 75 mg filmom obložene tablete |
|---|---|
| Former Name | Risbon 75 mg tablete |
| Marketing Authorisation Number | HR-H-913610371 |
| Active Substance | natrijev risedronat hemipentahidrat |
| Composition | jedna filmom obložena tableta sadrži 75 mg natrijevog risedronata, u obliku natrijevog risedronata hemipentahidrata |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Accord Healthcare B.V., Utrecht, Nizozemska
Accord Healthcare Polska Sp. z o.o., Pabianice, Poljska |
| Marketing Authorisation Holder | Accord Healthcare Polska Sp. z o.o., Ul. Tasmowa 7, Mazowieckie, Varšava, Poljska |
| Marketing Authorisation Date | 26.08.2019 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/560 |
| Registration Number | 381-12-01/70-19-19 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | M05BA07 |
| Medicinal product marketed in the Croatia | Nestašica |
| SmPC | download |
| PL | download |
